ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Genelabs Technologies

Include trials that are no longer recruiting patients.

4 studies were found.
1.RecruitingGL701 (Prestara™) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids
Condition: Systemic Lupus Erythematosus
2.CompletedA Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination with Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment with GLQ223 or Trichosanthin
Condition: HIV Infections
3.No longer recruitingStudy of GL701 in Men with Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
4.No longer recruitingTo assess prevention of bone loss in women with lupus receiving treatment with glucocorticoids
Condition: Lupus

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act